These effects together with the TGF-β1 lowering and Nrf2 stimulation resulted in blocking the pathological pathways that participated in the development of liver fibrosis including, TGF-β1/SMAD signaling, chronic inflammation, oxidative stress, and collagen deposition. This evidence concerns the gene TGFB1 and Hepatic fibrosis.